Production (Stage)
Evoke Pharma, Inc.
EVOK
$2.89
-$0.0574-1.95%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 30.11% | 186.88% | 90.10% | 30.99% | 18.14% |
| Total Receivables | 72.98% | 259.59% | 63.91% | 95.64% | 111.25% |
| Inventory | -9.63% | -7.62% | -2.28% | 6.05% | 61.36% |
| Prepaid Expenses | -25.60% | -17.30% | 287.07% | 3.12% | 4.89% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 522.22% | -7.58% | -62.90% | 138.79% | -45.69% |
| Total Current Assets | 30.33% | 152.50% | 79.07% | 35.95% | 25.19% |
|
|
|||||
| Total Current Assets | 30.33% | 152.50% | 79.07% | 35.95% | 25.19% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -47.48% | -- | -- | -- |
| Total Assets | 31.49% | 147.85% | 80.23% | 35.15% | 24.05% |
|
|
|||||
| Total Accounts Payable | 39.10% | 27.00% | 49.30% | 34.24% | 38.29% |
| Total Accrued Expenses | 36.29% | 8.11% | 209.98% | 294.75% | 414.81% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.23% | 1.19% | 37,213.43% | 9,369.70% | 5,370.46% |
| Total Finance Division Other Current Liabilities | 17.19% | 0.00% | 95.12% | -- | -- |
| Total Other Current Liabilities | 17.19% | 0.00% | 95.12% | -- | -- |
| Total Current Liabilities | 16.69% | 7.59% | 335.90% | 355.11% | 433.91% |
|
|
|||||
| Total Current Liabilities | 16.69% | 7.59% | 335.90% | 355.11% | 433.91% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 17.62% | 8.63% | 11.91% | 12.20% | 13.19% |
|
|
|||||
| Common Stock & APIC | 5.78% | 12.39% | 9.46% | 7.19% | 7.08% |
| Retained Earnings | -4.06% | -4.34% | -5.06% | -5.45% | -6.05% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 67.03% | 372.84% | 602.07% | 394.99% | 64.48% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 67.03% | 372.84% | 602.07% | 394.99% | 64.48% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 67.03% | 372.84% | 602.07% | 394.99% | 64.48% |
|
|
|||||